TGFB1 and cancer: Due to the complexity of the TGFβ’s highly context-dependent downstream mechanisms, developing therapeutics should first identify the stage of cancer progression optimal for a personalized, patient-specific treatment plan, which balances TGFβ’s pro-inflammatory and anti-inflammatory effects.